Literature DB >> 16511757

High rate of spontaneous negativity for hepatitis C virus RNA after establishment of chronic infection in Alaska Natives.

John D Scott1, Brian J McMahon, Dana Bruden, Daniel Sullivan, Chriss Homan, Carol Christensen, David R Gretch.   

Abstract

BACKGROUND: Hepatitis C virus (HCV) leads to chronic infection in 70%-85% of exposed patients. Spontaneous clearance of the virus after chronic infection is believed to occur rarely.
METHODS: Alaska Natives who tested positive for HCV antibodies were enrolled in a prospective study that began in 1994 and were followed up on a regular basis. Individuals who tested positive for HCV RNA on 3 separate dates, each of which were at least 1 year apart, were included. Being negative for the virus was defined as having at least 1 negative HCV RNA test result after chronic viremia had been established.
RESULTS: Of the 815 patients enrolled in the cohort, 139 met entry criteria and were observed for a mean period of 7.0 years. Eleven (8%) of the persons had at least 1 test in which HCV RNA was undetectable; 7 were classified as having either possible or probable clearance of the virus, corresponding to an annualized clearance rate of 0.74% per person-year (95% CI, 0.30%-1.53%). Of 9 patients who underwent subsequent HCV RNA testing, 5 (56%) had negative test results. A low HCV RNA level was significantly associated with spontaneous nondetectability of HCV RNA.
CONCLUSION: Spontaneous HCV RNA negativity during chronic HCV infection is a surprisingly frequent event and is associated with low HCV RNA titers. Knowledge of immunologic determinants of clearance may open up avenues of novel therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16511757     DOI: 10.1086/500938

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  19 in total

Review 1.  Opioids and HIV/HCV infection.

Authors:  Xu Wang; Ting Zhang; Wen-Zhe Ho
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-14       Impact factor: 4.147

2.  Spontaneous clearance of chronic hepatitis C virus infection is associated with appearance of neutralizing antibodies and reversal of T-cell exhaustion.

Authors:  Sukanya Raghuraman; Heiyoung Park; William O Osburn; Emily Winkelstein; Brian R Edlin; Barbara Rehermann
Journal:  J Infect Dis       Date:  2012-01-31       Impact factor: 5.226

Review 3.  Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine.

Authors:  Jason Grebely; Maria Prins; Margaret Hellard; Andrea L Cox; William O Osburn; Georg Lauer; Kimberly Page; Andrew R Lloyd; Gregory J Dore
Journal:  Lancet Infect Dis       Date:  2012-05       Impact factor: 25.071

4.  Modeling the impact of hepatitis C viral clearance on end-stage liver disease in an HIV co-infected cohort with targeted maximum likelihood estimation.

Authors:  Mireille E Schnitzer; Erica E M Moodie; Mark J van der Laan; Robert W Platt; Marina B Klein
Journal:  Biometrics       Date:  2013-11-13       Impact factor: 2.571

Review 5.  Chronic liver disease in Aboriginal North Americans.

Authors:  John D Scott; Naomi Garland
Journal:  World J Gastroenterol       Date:  2008-08-07       Impact factor: 5.742

6.  The inverse relationship between chronic HBV and HCV infections among injection drug users is associated with decades of age and drug use.

Authors:  F-C Tseng; B R Edlin; M Zhang; A Kral; M P Busch; B A Ortiz-Conde; T M Welzel; T R O'Brien
Journal:  J Viral Hepat       Date:  2008-05-27       Impact factor: 3.728

Review 7.  Update on hepatitis B and C virus diagnosis.

Authors:  Livia Melo Villar; Helena Medina Cruz; Jakeline Ribeiro Barbosa; Cristianne Sousa Bezerra; Moyra Machado Portilho; Letícia de Paula Scalioni
Journal:  World J Virol       Date:  2015-11-12

Review 8.  Coinfection with HIV-1 and HCV--a one-two punch.

Authors:  Arthur Y Kim; Raymond T Chung
Journal:  Gastroenterology       Date:  2009-06-21       Impact factor: 22.682

9.  Factors associated with spontaneous clearance of hepatitis C virus among illicit drug users.

Authors:  Jason Grebely; Jesse D Raffa; Calvin Lai; Mel Krajden; Brian Conway; Mark W Tyndall
Journal:  Can J Gastroenterol       Date:  2007-07       Impact factor: 3.522

10.  Seroprevalence of hepatitis B virus and hepatitis C virus among blood donors in Nyala, South Dar Fur, Sudan.

Authors:  Mustafa Abdalla Ali Abou; Yassir Mohammed Eltahir; Abdelwahid Saeed Ali
Journal:  Virol J       Date:  2009-09-23       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.